Skip to content

Study on phenotypic characteristics of pre - diabetes population(Yu stage)

Study on phenotypic characteristics of pre - diabetes population(Yu stage)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17011441
Enrollment
Unknown
Registered
2017-05-20
Start date
2017-05-23
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-diabetes

Interventions

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medicine Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for people with pre diabetes (Yu stage) 1) meet the pre diabetes diagnostic criteria; 2) Age 18-70 years; 3) those who had not used diabetes related drugs before; 4) Those who sign the informed consent form. 2. Inclusion criteria for healthy people 1) Age: 18-70 years old; 2) Meet the diagnostic criteria of healthy people, and the constitution of traditional Chinese medicine is judged as peaceful; 3) Blood glucose within normal range; 4) Those who sign the informed consent form. 3. Inclusion criteria for diabetes patients: 1) meet the diagnostic criteria of diabetes; 2) Age 18-70 years; 3) Those who sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Stress state of elevated blood glucose or secondary to elevated blood glucose; 2. Patients suffered from mental disease; 3. Taking hypoglycemic drugs; 4. Proliferative retinopathy requires laser treatment; 5. Diabetic complications, or other serious disease; 6. Acute cardiovascular and cerebrovascular events or myocardial infarction in last 6months; 7. Due to various reasons can not cooperate with the test; 8. Women who were in pregnancy or in lactation; 9. Blood pressure cannot be well controlled; dosage and types of antihypertensive drugs cannot remain stable.

Design outcomes

Primary

MeasureTime frame
0 - hr plasma glucose;2- hr plasma glucose;TCM Syndrome;

Secondary

MeasureTime frame
HbA1C;Insulin secretion (fasting);Lipids (CHO, TG, HDL-c, LDL-c);waist;weight;hip;Renal function (BUN, CR, UA);liver function (ALT, AST, ALP, gama-GT, TBIL);blood routine test+C-reactive protein;urine routine test;stool test;Electrocardiogram;Multiomics detection (metagenomics, metabolomics, transcriptomics);Inflammatory factor;

Countries

China

Contacts

Public ContactXiaolin Tong

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

xiaolintong66@sina.com+86 13910662116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026